272 related articles for article (PubMed ID: 31234952)
21. GPER-mediated proliferation and estradiol production in breast cancer-associated fibroblasts.
Luo H; Yang G; Yu T; Luo S; Wu C; Sun Y; Liu M; Tu G
Endocr Relat Cancer; 2014 Apr; 21(2):355-69. PubMed ID: 24481325
[TBL] [Abstract][Full Text] [Related]
22. Two novel GPER agonists induce gene expression changes and growth effects in cancer cells.
Lappano R; Rosano C; Santolla MF; Pupo M; De Francesco EM; De Marco P; Ponassi M; Spallarossa A; Ranise A; Maggiolini M
Curr Cancer Drug Targets; 2012 Jun; 12(5):531-42. PubMed ID: 22414008
[TBL] [Abstract][Full Text] [Related]
23. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J
Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983
[TBL] [Abstract][Full Text] [Related]
24. Activation of G-Protein-Coupled Estrogen Receptor Inhibits the Migration of Human Nonsmall Cell Lung Cancer Cells via IKK-β/NF-κB Signals.
Zhu G; Huang Y; Wu C; Wei D; Shi Y
DNA Cell Biol; 2016 Aug; 35(8):434-42. PubMed ID: 27082459
[TBL] [Abstract][Full Text] [Related]
25. G protein-coupled estrogen receptor 1 agonist G-1 induces cell cycle arrest in the mitotic phase, leading to apoptosis in endometriosis.
Mori T; Ito F; Matsushima H; Takaoka O; Tanaka Y; Koshiba A; Kusuki I; Kitawaki J
Fertil Steril; 2015 May; 103(5):1228-35.e1. PubMed ID: 25724739
[TBL] [Abstract][Full Text] [Related]
26. Activation of G-protein coupled estrogen receptor inhibits the proliferation of cervical cancer cells via sustained activation of ERK1/2.
Zhang Q; Wu YZ; Zhang YM; Ji XH; Hao Q
Cell Biochem Funct; 2015 Apr; 33(3):134-42. PubMed ID: 25753185
[TBL] [Abstract][Full Text] [Related]
27. Evidence for G-Protein-Coupled Estrogen Receptor as a Pronatriuretic Factor.
Gohar EY; Daugherty EM; Aceves JO; Sedaka R; Obi IE; Allan JM; Soliman RH; Jin C; De Miguel C; Lindsey SH; Pollock JS; Pollock DM
J Am Heart Assoc; 2020 May; 9(10):e015110. PubMed ID: 32390531
[TBL] [Abstract][Full Text] [Related]
28. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
Cirillo F; Lappano R; Bruno L; Rizzuti B; Grande F; Guzzi R; Briguori S; Miglietta AM; Nakajima M; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Aug; 38(1):335. PubMed ID: 31370872
[TBL] [Abstract][Full Text] [Related]
29. GPER promotes tamoxifen-resistance in ER+ breast cancer cells by reduced Bim proteins through MAPK/Erk-TRIM2 signaling axis.
Yin H; Zhu Q; Liu M; Tu G; Li Q; Yuan J; Wen S; Yang G
Int J Oncol; 2017 Oct; 51(4):1191-1198. PubMed ID: 28902352
[TBL] [Abstract][Full Text] [Related]
30. The GPER agonist G-1 induces mitotic arrest and apoptosis in human vascular smooth muscle cells independent of GPER.
Gui Y; Shi Z; Wang Z; Li JJ; Xu C; Tian R; Song X; Walsh MP; Li D; Gao J; Zheng XL
J Cell Physiol; 2015 Apr; 230(4):885-95. PubMed ID: 25204801
[TBL] [Abstract][Full Text] [Related]
31. Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs).
Vivacqua A; De Marco P; Santolla MF; Cirillo F; Pellegrino M; Panno ML; Abonante S; Maggiolini M
Oncotarget; 2015 Jun; 6(18):16573-87. PubMed ID: 26030000
[TBL] [Abstract][Full Text] [Related]
32. G protein-coupled estrogen receptor 1 (GPER-1) and agonist G-1 inhibit growth of ovarian cancer cells by activation of anti-tumoral transcriptome responses: impact of GPER-1 mRNA on survival.
Schüler-Toprak S; Skrzypczak M; Ignatov T; Ignatov A; Ortmann O; Treeck O
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3175-3188. PubMed ID: 32813115
[TBL] [Abstract][Full Text] [Related]
33. GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression.
Santolla MF; Vivacqua A; Lappano R; Rigiracciolo DC; Cirillo F; Galli GR; Talia M; Brunetti G; Miglietta AM; Belfiore A; Maggiolini M
Cells; 2019 Mar; 8(3):. PubMed ID: 30866584
[TBL] [Abstract][Full Text] [Related]
34. The activation of G protein-coupled estrogen receptor induces relaxation via cAMP as well as potentiates contraction via EGFR transactivation in porcine coronary arteries.
Yu X; Stallone JN; Heaps CL; Han G
PLoS One; 2018; 13(1):e0191418. PubMed ID: 29360846
[TBL] [Abstract][Full Text] [Related]
35. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.
Vivacqua A; Romeo E; De Marco P; De Francesco EM; Abonante S; Maggiolini M
Breast Cancer Res Treat; 2012 Jun; 133(3):1025-35. PubMed ID: 22147081
[TBL] [Abstract][Full Text] [Related]
36. A novel estrogen receptor GPER mediates proliferation induced by 17β-estradiol and selective GPER agonist G-1 in estrogen receptor α (ERα)-negative ovarian cancer cells.
Liu H; Yan Y; Wen H; Jiang X; Cao X; Zhang G; Liu G
Cell Biol Int; 2014 May; 38(5):631-8. PubMed ID: 24446390
[TBL] [Abstract][Full Text] [Related]
37. G-protein-coupled estrogen receptor protects retinal ganglion cells via inhibiting endoplasmic reticulum stress under hyperoxia.
Li R; Wang Y; Chen P; Meng J; Zhang H
J Cell Physiol; 2021 May; 236(5):3780-3788. PubMed ID: 33151568
[TBL] [Abstract][Full Text] [Related]
38. GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells.
Weißenborn C; Ignatov T; Poehlmann A; Wege AK; Costa SD; Zenclussen AC; Ignatov A
J Cancer Res Clin Oncol; 2014 Apr; 140(4):663-71. PubMed ID: 24515910
[TBL] [Abstract][Full Text] [Related]
39. Bisphenol AF exerts estrogenic activity in MCF-7 cells through activation of Erk and PI3K/Akt signals via GPER signaling pathway.
Lei B; Sun S; Zhang X; Feng C; Xu J; Wen Y; Huang Y; Wu M; Yu Y
Chemosphere; 2019 Apr; 220():362-370. PubMed ID: 30590302
[TBL] [Abstract][Full Text] [Related]
40. The G Protein-Coupled Estrogen Receptor Agonist G-1 Inhibits Nuclear Estrogen Receptor Activity and Stimulates Novel Phosphoproteomic Signatures.
Smith LC; Ralston-Hooper KJ; Ferguson PL; Sabo-Attwood T
Toxicol Sci; 2016 Jun; 151(2):434-46. PubMed ID: 27026707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
